Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.
Ohtaki Y, Shimizu K, Kakegawa S, Nagashima T, Nakano T, Atsumi J, Enokida Y, Igai H, Ibe T, Sugano M, Kamiyoshihara M, Kawashima O, Kaira K, Sunaga N, Takeyoshi I.
Ohtaki Y, et al. Among authors: kaira k.
Mol Clin Oncol. 2014 Mar;2(2):187-196. doi: 10.3892/mco.2013.237. Epub 2013 Dec 31.
Mol Clin Oncol. 2014.
PMID: 24649331
Free PMC article.